Location History:
- Niigata, JP (2020)
- Okayama, JP (2024)
Company Filing History:
2 out of 70 
1 out of 137 
1 out of 113 
Years Active: 2020-2024
Title: Innovations by Hiroki Sato
Introduction
Hiroki Sato is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of medical science, particularly in the development of innovative pharmaceutical compositions. With a total of two patents to his name, Sato's work focuses on addressing critical health issues such as cancer metastasis and inflammatory diseases.
Latest Patents
Sato's latest patents include the "Anti-S100A8/A9 antibody and use thereof." This invention provides a substance capable of effectively suppressing cancer metastasis or a pharmaceutical composition that acts on inflammatory diseases. The composition contains an antibody or an antibody fragment that has antigen-binding activity for the S100A8/A9 heterodimer. This invention blocks the interaction between S100A8/A9 and its receptors, thereby strongly suppressing cancer metastasis both in vitro and in vivo, or alleviating inflammation. The anti-S100A8/A9 antibody can significantly impact cancer treatment and inflammatory conditions through its unique mechanism of action.
Career Highlights
Hiroki Sato has worked at prestigious institutions such as Niigata University and Okayama University. His research and innovations have contributed to advancements in medical science, particularly in the development of therapeutic agents for serious health conditions. His dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
Sato has collaborated with notable colleagues, including Masakiyo Sakaguchi and Shinichi Toyooka. These collaborations have further enhanced his research capabilities and have led to significant advancements in his projects.
Conclusion
Hiroki Sato's contributions to medical science through his innovative patents demonstrate his commitment to improving health outcomes. His work in developing effective treatments for cancer and inflammatory diseases highlights the importance of research and innovation in addressing critical health challenges.